Status:
COMPLETED
Multiple Risk Behavior Intervention in Health Care Settings
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Health Behavior
Risk Reduction Behavior
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study (aka Healthy Directions2 or HD2) builds on an earlier study titled Healthy Directions (aka Healthy Directions 1 or HD1). HD1 was an intervention designed to target cancer prevention among m...
Detailed Description
HD2 conducted a randomized control trial at two metropolitan Harvard Vanguard Medical Associates (HVMA) sites. The unit of randomization was the primary care provider. Providers were randomized to one...
Eligibility Criteria
Inclusion
- HVMA patient seeing a provider participating in HD2 for annual well visit
- 18 years of age or older
- Able to read in English
Exclusion
- No diagnosis of dementia or psychotic disorders
- Undergone cancer treatment within past year
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
2440 Patients enrolled
Trial Details
Trial ID
NCT01415492
Start Date
March 1 2009
End Date
January 1 2012
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harvard Vanguard Medical Associates
Boston, Massachusetts, United States, 02215